Reduction of hospital-onset methicillin-resistant Staphylococcus aureus (MRSA) bacteremia with the use of twice daily alcohol-based nasal antiseptic in intensive care units
American Journal of Infection Control · 2025
DOI: 10.1016/j.ajic.2025.08.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Infection Control, 2025. Verfasst von Sarah Prascius und 5 weiteren Autor:innen. Beteiligte Einrichtung: Henry Ford West Bloomfield, West Bloomfield, MI. Electronic address: sprasci1@hfhs.org. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections, Anti-Infective Agents, Local, Bacteremia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Themen: Intensivpflege
Abstract (Originalsprache)
BACKGROUND: A 191-bed hospital within a Midwest health care system experienced an increase in hospital acquired Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. In response, the hospital sought a targeted intervention for MRSA prevention within 2 intensive care units using an alcohol based nasal antiseptic. METHODS: In August 2021, Infection Prevention and Control (IPC) partnered with Nursing and the alcohol-based nasal antiseptic product vendor to implement the product in the 2 units. Nasal antiseptic was administered twice daily. To measure process adherence, a report was created within the electronic medical record to track compliance. Patient tracking and communication of data reports to nurse leadership by IPC began shortly afterward. RESULTS: MRSA standardized infection ratios (SIR) declined with an SIR of 1.18 in 2021 to an SIR of 0.90 in 2023. The total number of MRSA cases decreased from 2021 to 2022 with 4 cases and 1 case, respectively. DISCUSSION: Barriers were identified, including personnel permitted to administer alcohol-based antiseptic, product location, and administration documentation. As these were addressed, compliance in administration began to increase. Manually tracking compliance was later replaced with an automated report for sustainability purposes. Options available to analyze the data were limited due to lack of control data. CONCLUSION: Implementation of universal decolonization using twice daily alcohol based nasal antiseptic can be accomplished and assessed with the development of an electronic data tracking process.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Henry Ford West Bloomfield, West Bloomfield, MI. Electronic address: sprasci1@hfhs.org.
- Henry Ford West Bloomfield, West Bloomfield, MI.
Zitieren
APA
Prascius, S., Wells, A., Collier, A. M., Renard, A., Hooper, D., & Stein, T. (2025). Reduction of hospital-onset methicillin-resistant Staphylococcus aureus (MRSA) bacteremia with the use of twice daily alcohol-based nasal antiseptic in intensive care units. American Journal of Infection Control. https://doi.org/10.1016/j.ajic.2025.08.006
Vancouver
Prascius S, Wells A, Collier AM, Renard A, Hooper D, Stein T. Reduction of hospital-onset methicillin-resistant Staphylococcus aureus (MRSA) bacteremia with the use of twice daily alcohol-based nasal antiseptic in intensive care units. American Journal of Infection Control. 2025. doi:10.1016/j.ajic.2025.08.006
BibTeX
@article{Prascius2025,
author = {Prascius, Sarah and Wells, Alex and Collier, Anne Marie and Renard, Amanda and Hooper, Deanna and Stein, Tricia},
title = {Reduction of hospital-onset methicillin-resistant Staphylococcus aureus (MRSA) bacteremia with the use of twice daily alcohol-based nasal antiseptic in intensive care units},
journal = {American Journal of Infection Control},
year = {2025},
doi = {10.1016/j.ajic.2025.08.006}
}
EUVIMED